Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 50018025
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50431015(CHEMBL2338329 | US9115085, Compound A Form A | US9...)
Affinity DataEC50:  6.11E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607005(CHEMBL5219927)
Affinity DataEC50:  9.27E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607006(CHEMBL5218506)
Affinity DataEC50:  5.54E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607007(CHEMBL5219872)
Affinity DataEC50:  4.91E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607008(CHEMBL5218607)
Affinity DataEC50:  7.97E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607009(CHEMBL5218673)
Affinity DataEC50:  190nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607010(CHEMBL5218720)
Affinity DataEC50:  1.25E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607011(CHEMBL5219277)
Affinity DataEC50:  100nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607012(CHEMBL5220549)
Affinity DataEC50:  4.46E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetEgl nine homolog 1(Human)
Tianjin Institute of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607013(CHEMBL5219134)
Affinity DataEC50:  10nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed